Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03583008 · ClinicalTrials.gov registry record · NA
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT03583008 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 112 participants.
The verdict
NCT03583008, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The SUPPORT-AF study aims to improve rates of anticoagulation (AC) in atrial fibrillation (AF) patients by developing and delivering supportive tools and educational materials to providers treating patients with AF. The investigators hypothesize that AC percentage will increase among providers receiving tools and educational content.
Interventions
- BEHAVIORAL Anticoagulation (AC) Intervention--Academic Detailing
- BEHAVIORAL Anticoagulation (AC) Intervention--Prescribing Practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03583008
The ClinicalTrials.gov registry entry for NCT03583008 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anticoagulation (AC) Intervention--Academic Detailing is the first listed.
NCT03583008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03583008 about?
NCT03583008 is a clinical study titled "Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF". The SUPPORT-AF study aims to improve rates of anticoagulation (AC) in atrial fibrillation (AF) patients by developing and delivering supportive tools and educational materials to providers treating patients with AF. The investigators hypothesize that AC percentage will increase among providers recei...
What is the current status of trial NCT03583008?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2018-06-11. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT03583008?
The interventions under investigation include: Anticoagulation (AC) Intervention--Academic Detailing (BEHAVIORAL), Anticoagulation (AC) Intervention--Prescribing Practices (BEHAVIORAL).
Who is sponsoring clinical trial NCT03583008?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.